Invesco’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.21M Buy
33,384
+10,510
+46% +$308K ﹤0.01% 2828
2026
Q1
$565K Buy
22,874
+3,183
+16% +$55.7K ﹤0.01% 3113
2025
Q4
$333K Buy
19,691
+6,213
+46% +$109K ﹤0.01% 3344
2025
Q3
$293K Hold
13,478
– – ﹤0.01% 3427
2025
Q2
$192K Buy
+13,478
New +$213K ﹤0.01% 3520

Other funds holding ETON

Invesco's ETON Position: Q2 2026 in Review

Invesco increased its Eton Pharmaceutcials (ETON) stake by 46% in Q2 2026, buying an estimated $308K and bringing the position to 33,384 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2828.

Invesco first reported a position in ETON in Q2 2025 and has held it in 5 quarters since. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Invesco held 33,384 shares of Eton Pharmaceutcials worth $1.21M as of Q2 2026.
  • Invesco bought 10,510 Eton Pharmaceutcials shares in Q2 2026, an estimated $308K.
  • Eton Pharmaceutcials made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #2828 holding.
  • Invesco first reported a position in Eton Pharmaceutcials in Q2 2025 and has held it in 5 quarters since.
  • 164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.